社区健康工作者在镰状细胞贫血中的随机对照供方盲法试验:对血液学变量与羟基脲依从性的影响
该随机对照供方盲法试验将224例符合羟基脲治疗条件的镰状细胞贫血成人分为实验组(接受患者导航员个案管理与教育)和对照组(仅接受专科治疗),比较血液学指标与羟基脲依从性。结果显示实验组6个月时平均胎儿血红蛋白较高,但12个月时两组胎儿血红蛋白及白细胞计数、中性粒细胞绝对计数、总血红蛋白、血小板计数、平均红细胞体积均相似;12个月时实验组漏服羟基脲剂量更少、近期配药天数更短。作者结论为在专科治疗中加入患者导航员可改善羟基脲依从性行为,但未带来血液学改善。
要点
- 224例符合羟基脲治疗条件的镰状细胞贫血成人随机分组,医生对分组设盲。
- 12个月时实验组漏服羟基脲剂量均值1.8 vs 对照组4.5(P=0.0098)。
- 12个月时实验组近期配药天数均值53.8 vs 对照组92天(P=0.0082)。
核心结论
- 在专科治疗中加入患者导航员可改善羟基脲依从性行为,但未带来血液学改善。
研究设计与样本
- 随机对照供方盲法试验,纳入224例符合羟基脲治疗条件的镰状细胞贫血成人。
- 所有患者由受过培训的医生按照标准化羟基脲处方方案提供治疗。
- 实验组接受患者导航员通过多次接触提供的个案管理与教育,其余患者为对照组,仅接受专科治疗。
- 研究医生对分组设盲,且不与患者导航员互动。
- 在基线、6个月和12个月评估并比较实验室参数与羟基脲依从性指标。
主要发现
- 实验组6个月时平均胎儿血红蛋白水平高于对照组。
- 12个月时两组平均胎儿血红蛋白相似,白细胞计数、中性粒细胞绝对计数、总血红蛋白、血小板计数和平均红细胞体积也相似。
- 12个月时实验组漏服羟基脲剂量的患者更少(均值1.8 vs 对照组4.5,P=0.0098)。
- 12个月时实验组近期配药天数更短(均值53.8 vs 对照组92天,中位数27.5 vs 62天,P=0.0082)。
- 平均羟基脲剂量两组大致相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hydroxyurea (hydroxycarbamide) (HU) for sickle cell anaemia (SCA) is underutilised. Case management is an evidence-based health management strategy and in this regard patient navigators (PNs) may provide case management for SCA. We hypothesised that HU-eligible patients exposed to PNs would have improved indicators of starting HU and HU adherence. We randomised 224 HU-eligible SCA adults into the Start Healing in Patients with Hydroxyurea (SHIP-HU) Trial. All patients received care from trained physicians using standardised HU prescribing protocols. Patients in the Experimental arm received case management and education from PNs through multiple contacts. All other patients were regarded as the Control arm and received specialty care alone. Study physicians were blinded to the study arms and did not interact with PNs. At baseline, 6 and 12 months we assessed and compared laboratory parameters and HU adherence indicators. Experimental patients had higher 6-month mean fetal haemoglobin (HbF) levels than controls. But at 12 months, mean HbF was similar, as were white blood cell count, absolute neutrophil count, total haemoglobin, platelet count and mean corpuscular volume. At 12 months there were fewer experimental patients missing HU doses than controls (mean 1·8 vs. 4·5, P = 0·0098), and more recent HU prescriptions filled than for controls (mean 53·8 vs. 92 days, median 27·5 vs. 62 days, P = 0·0082). Mean HU doses were largely similar. We detected behavioural improvements in HU adherence but no haematological improvements by adding PNs to specialty care.
引用
- Smith WR, McClish DK, Lottenberg R, et al. A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. Br J Haematol. 2021. PMID: 34786695. doi:10.1111/bjh.17952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。